Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,038 | 29,481 | 31,902 | 66,945 | 91,538 |
| Marketable Securities | 55,889 | 49,473 | 49,864 | 21,635 | 9,198 |
| Receivables | 7,953 | 10,842 | 10,060 | 9,167 | 8,476 |
| Inventories | 30,155 | 27,825 | 27,690 | 27,566 | 29,013 |
| Other current assets | 0 | 0 | 0 | 0 | 4,584 |
| TOTAL | $136,561 | $126,566 | $125,432 | $131,129 | $148,761 |
| Non-Current Assets | |||||
| PPE Net | 14,713 | 11,101 | 7,665 | 6,605 | 5,974 |
| Investments And Advances | 31,250 | 19,444 | 18,471 | 20,050 | 5,623 |
| Intangibles | 212,844 | 219,754 | 220,453 | 221,161 | 214,152 |
| Other Non-Current Assets | 10,516 | 15,216 | 15,219 | 16,196 | 24,977 |
| TOTAL | $269,323 | $265,515 | $261,808 | $264,012 | $250,726 |
| Total Assets | $405,884 | $392,081 | $387,240 | $395,141 | $399,487 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,997 | 7,492 | 10,051 | 10,449 | 10,943 |
| Accounts payable and accrued liabilities | 1,486 | 2,890 | 3,209 | 3,297 | 3,360 |
| Accrued Expenses | 11,974 | 10,905 | 9,311 | 8,213 | 12,123 |
| Other current liabilities | 2,279 | 3,681 | 3,575 | 3,929 | 4,233 |
| TOTAL | $22,979 | $27,146 | $28,312 | $27,723 | $32,734 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | N/A | 2,499 | 5,075 |
| Other Non-Current Liabilities | 10,828 | 11,007 | 11,598 | 12,165 | 12,645 |
| TOTAL | $11,017 | $11,196 | $11,773 | $14,794 | $17,844 |
| Total Liabilities | $33,996 | $38,342 | $40,085 | $42,517 | $50,578 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,300 | 48,148 | 47,905 | 47,561 | 47,000 |
| Common Shares | 48 | 48 | 48 | 48 | 47 |
| Retained earnings | -339,696 | -350,766 | -351,387 | -335,549 | -335,101 |
| Other shareholders' equity | 132 | 130 | 71 | 33 | 24 |
| TOTAL | $371,888 | $353,739 | $347,155 | $352,624 | $348,909 |
| Total Liabilities And Equity | $405,884 | $392,081 | $387,240 | $395,141 | $399,487 |